Our experiments suggest so far that exogenous expression of KDM5B can direct melanoma towards a slow-cycling tumor phenotype across the majority of tumor cells, where different molecular mechanisms might cooperate to prevent cell proliferation. Here, KDM5B is linked to neoplasm.